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Background
Soybean is an important food and known allergen. The
hexameric major storage protein glycinin is an important
soybean allergen (Gly m 6) but the knowledge about Gly
m 6 IgE-epitopes is limited. Novel diagnostic and thera-
peutic approaches may be developed on the basis of
known IgE epitopes.
Objective
To identify IgE epitopes of Gly m 6 in a multi-peptide
microarray.
Methods
11 subjects with clinically confirmed soybean allergy and
sIgE against rGly m 6 were enrolled in this study. Synthetic
overlapping peptides (15-mers, 4 aa offset) representing the
amino acid sequences of G1 and G5, two representative
subunits of Gly m 6, were spotted onto CelluSpot™ slides
and analyzed for IgE-binding, respectively. The sequences
of IgE-binding peptides were allocated to the respective
surface areas of the 3D-structures of G1 and G5. Allergen-
specific IgE-binding to Gly m 6 peptides was verified by
inhibition with rG1, rG5, and soy extract, respectively.
Results
Gly m 6 peptides bound IgE of 100% (11/11) of the study
sera. IgE-binding peptides covered 75% and 91% of the
primary sequence of G1 and G5 subunits, respectively.
Peptide-specific IgE-binding could be inhibited in a dose-
dependent manner by rG1, rG5, and soy protein extract.
24 of G1 and 32 of G5 peptides bound sIgE by more than
25% of the sera. Allocation of these IgE-binding peptides
to the surface of the structurally resolved Gly m 6 subu-
nits showed a partial surface accessibility of the peptide
sequences and yielded 15 and 18 putative IgE epitopes
for G1 and G5, respectively. Comparison of the IgE-
binding patterns in terms of severity of clinical symptoms
or age showed a positive but statistically insignificant
correlation.
Conclusions
Allergen-specific multi-peptide microarray is a useful tool
to identify IgE epitopes of food allergens. The identified
putative IgE epitopes need to be further analyzed on the
protein level. The knowledge of allergen-specific IgE epi-
topes allows the i) generation of hypoallergenic allergen
variants for potential use as vaccine or therapeutic agent,
ii) development of advanced diagnostic tools, and iii)
assessment of the allergenicity of novel biotechnology
products.
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